Hsbc Holdings PLC Lowers Stake in Teladoc Health, Inc. $TDOC

Key Points

• HSBC Holdings PLC reduced its stake in Teladoc Health by 53.6%, now owning approximately 0.11% of the company, following the sale of 212,946 shares.
• Several institutional investors have increased their positions in Teladoc Health, with Golden State Wealth Management and National Bank of Canada increasing their holdings by 102.6% and 79.4% respectively.
• Teladoc Health reported a revenue of $631.90 million for the last quarter, which exceeded analyst expectations, though it had a negative net margin of 8.16%.

Hsbc Holdings PLC decreased its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 53.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 184,252 shares of the health services provider's stock after selling 212,946 shares during the period. Hsbc Holdings PLC owned 0.11% of Teladoc Health worth $1,481,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in TDOC. Golden State Wealth Management LLC increased its stake in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares during the last quarter. National Bank of Canada FI increased its stake in Teladoc Health by 79.4% in the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock valued at $28,000 after buying an additional 1,581 shares during the last quarter. Westside Investment Management Inc. increased its stake in Teladoc Health by 16.8% in the 1st quarter. Westside Investment Management Inc. now owns 10,750 shares of the health services provider's stock valued at $86,000 after buying an additional 1,550 shares during the last quarter. Brucke Financial Inc. purchased a new stake in Teladoc Health in the 4th quarter valued at about $92,000. Finally, AE Wealth Management LLC purchased a new stake in Teladoc Health in the 1st quarter valued at about $93,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on TDOC shares. Bank of America dropped their target price on shares of Teladoc Health from $8.00 to $7.00 and set a "neutral" rating on the stock in a research note on Wednesday, May 28th. Mizuho began coverage on shares of Teladoc Health in a research note on Friday, July 25th. They set a "neutral" rating and a $10.00 price target for the company. Truist Financial decreased their price target on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating for the company in a research note on Tuesday, May 27th. Wells Fargo & Company decreased their price target on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research note on Thursday, May 8th. Finally, Evercore ISI raised their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Six analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $9.80.

Teladoc Health Price Performance

Shares of TDOC traded up $0.13 during mid-day trading on Wednesday, reaching $7.77. 4,018,424 shares of the stock traded hands, compared to its average volume of 5,485,458. The firm has a fifty day moving average price of $7.80 and a 200 day moving average price of $7.94. The company has a market cap of $1.37 billion, a price-to-earnings ratio of -6.53 and a beta of 1.84. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.08. The firm had revenue of $631.90 million during the quarter, compared to analyst estimates of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The business's revenue for the quarter was down 1.6% on a year-over-year basis. During the same period in the previous year, the business earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, equities research analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.